(EMAILWIRE.COM, August 20, 2019 ) According to the new market research report "Artificial Stem Cells Market by Application (Cardiovascular Disease, Neurological Disorders, Other Applications (Cancer, Diabetes, Gastrointestinal, Musculoskeletal Disorders)), Region (North America (US, Canada}, Europe, APAC, RoW) - Global Forecast to 2028", published by MarketsandMarkets™

The major factors driving the Artificial Stem Cells Market include ethical concerns regarding embryonic stem cells and the risk of tumor formation and immune rejection of natural stem cells.
The cardiovascular diseases segment is expected to command the largest share of the overall Artificial Stem Cells Market during the forecast period.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=4959435

The Artificial Stem Cells Market, by application, is estimated to be dominated by the cardiovascular diseases segment in 2023. This is attributed to the fact that the Artificial Stem Cellss have been firstly developed for cardiac tissue and are tested in mice models. After the successful pre-clinical testing of cardiac Artificial Stem Cellss, these cells will enter the clinical phase of development and are expected to hit the market by 2023.

Browse and in-depth TOC on "Artificial Stem Cells Market"
4 - Tables
17 - Figures
55 - Pages

North America to lead the Artificial Stem Cells Market with accelerated R&D activities in stem cell therapy research.

North America is estimated to account for the largest share of the market in 2023. North America is the pioneer of Artificial Stem Cells technology. Also, North America leads in the R&D of stem cell therapies globally, with the registration of the highest number of clinical trials (more than 1400) on stem cells till 2018. This is further backed by the high rate of adoption of advanced therapies in the US (more than 600 stem cell therapy clinics in the US in 2016).

Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=4959435

The key developers of Artificial Stem Cells technology are North Carolina State University (NCSU) (US) and Zhengzhou University (China).